These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15140124)

  • 1. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.
    Quiroga T; Goycoolea M; Muñoz B; Morales M; Aranda E; Panes O; Pereira J; Mezzano D
    J Thromb Haemost; 2004 Jun; 2(6):892-8. PubMed ID: 15140124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttal.
    Favaloro EJ
    J Thromb Haemost; 2004 Dec; 2(12):2280-2; author reply 2283-5. PubMed ID: 15613055
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
    Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
    Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls.
    Quiroga T; Goycoolea M; Panes O; Aranda E; Martínez C; Belmont S; Muñoz B; Zúñiga P; Pereira J; Mezzano D
    Haematologica; 2007 Mar; 92(3):357-65. PubMed ID: 17339185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
    Podda GM; Bucciarelli P; Lussana F; Lecchi A; Cattaneo M
    J Thromb Haemost; 2007 Dec; 5(12):2393-8. PubMed ID: 18034764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
    Favaloro EJ; Facey D; Henniker A
    Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttal.
    Hajdenberg J
    J Thromb Haemost; 2004 Dec; 2(12):2282-3; author reply 2283-5. PubMed ID: 15613056
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
    Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
    Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of the PFA-100.
    Favaloro EJ
    Curr Opin Hematol; 2002 Sep; 9(5):407-15. PubMed ID: 12172459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis].
    Ridefelt P; Egberg N; Hillarp A; Lethagen S; Tengborn L
    Lakartidningen; 2001 Sep; 98(37):3922-4. PubMed ID: 11586831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency.
    Wuillemin WA; Gasser Ka; Zeerleder SS; Lämmle B
    Swiss Med Wkly; 2002 Aug; 132(31-32):443-8. PubMed ID: 12457302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ISTH bleeding assessment tool and platelet function analyzer in children with mild inherited platelet function disorders.
    Alhaj D; Hagedorn N; Cuntz F; Reschke M; Schuldes J; Ruthenberg J; Bakchoul T; Greinacher A; Holzhauer S
    Eur J Haematol; 2024 Jul; 113(1):54-65. PubMed ID: 38549165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the platelet function analyser (PFA-100/200) for exclusion or detection of von Willebrand disease: A study 22 years in the making.
    Favaloro EJ
    Thromb Res; 2020 Apr; 188():17-24. PubMed ID: 32036157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
    Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
    Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skin and mucous membrane hemorrhages: clinical assessment, study sequence and relative frequency of hereditary diseases of the hemostasis in a Chilean population].
    Quiroga T; Pérez M; Rodríguez S; Muñoz B; Aranda E; Morales M; Verdugo P; Pereira J; Mezzano D
    Rev Med Chil; 1997 Apr; 125(4):409-18. PubMed ID: 9460281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of the PFA-100 in the identification of von Willebrand disease: a concise review.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Jul; 32(5):537-45. PubMed ID: 16862528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations.
    Favaloro EJ
    Haemophilia; 2001 Mar; 7(2):170-9. PubMed ID: 11260277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.